US73245B1070
US73245B1070
SBC Medical Group Holdings Inco
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 557.43M EUR | 315.94M EUR | 428.77M EUR | 442.11M EUR |
Enterprise Value | 428.9M EUR | 179.86M EUR | 313.37M EUR | 329.97M EUR |
Valuation Multiples | ||||
Trailing P/E | 11.53x | 6.44x | 10.51x | 15x |
Forward P/E | 10.04x | -- | -- | -- |
Price to Sales | 3.18x | 1.8x | 2.53x | 3.5x |
Price to Book | 2.11x | 1.2x | 1.68x | 1.78x |
EV/Revenue | 2.45x | 1.03x | 1.85x | 2.61x |
EV/EBITDA | 6.25x | 2.39x | 4.45x | 6.38x |
Price to FCF (P/FCF) | 8.82x | 5.23x | 14.55x | 21.26x |
EV/FCF | 6.79x | 2.98x | 10.63x | 15.87x |
FCF Yield | 11.34% | 19.11% | 6.87% | 4.7% |